Are Mercury Laboratories Ltd latest results good or bad?

54 minutes ago
share
Share Via
Mercury Laboratories Ltd's latest results show revenue growth of 11.39% quarter-on-quarter to ₹20.44 crores, but profitability is a concern with a net profit of ₹1.23 crores and a decline in operating margins to 9.93%, indicating ongoing operational challenges. Overall, while sales are improving, significant margin erosion raises doubts about the company's financial health.
Mercury Laboratories Ltd's latest financial results for the quarter ended March 2026 reveal a complex operational landscape characterized by both revenue growth and profitability challenges. The company reported net sales of ₹20.44 crores, reflecting an 11.39% increase compared to the previous quarter, which contrasts with a slight year-on-year decline of 1.06%. This sequential growth in sales indicates some positive momentum; however, it is overshadowed by a significant contraction in profitability.
Net profit for the same quarter was recorded at ₹1.23 crores, which shows a 23% increase from the previous quarter, yet this figure also represents a year-on-year decrease of 1.06%. The operating margin, a critical indicator of operational efficiency, fell to 9.93%, marking a notable decline from 13.73% in the preceding quarter and indicating pressures on cost management and pricing strategies. The operational profit before depreciation, interest, tax, and other income (PBDIT) dropped sharply to ₹2.03 crores, the lowest in recent history, which raises concerns about the company's ability to sustain profitability despite the revenue growth. Employee costs have also risen, contributing to the margin pressures. In terms of return ratios, the return on equity (ROE) stood at 8.95%, while the return on capital employed (ROCE) was at 9.20%, both figures indicating below-average performance relative to industry standards. The company's balance sheet remains relatively healthy, with low long-term debt and adequate liquidity, but the absence of institutional interest suggests a lack of confidence in its growth prospects. Overall, while Mercury Laboratories Ltd demonstrated some top-line growth in its latest results, the significant erosion of margins and ongoing profitability challenges highlight the operational difficulties the company is facing. Additionally, the company saw an adjustment in its evaluation, reflecting the complexities of its financial performance and market position.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News